March 14th, 2010
Does Fenofibrate ACCORD with the Treatment of Diabetes?
henrynginsberg and Andrew M. Kates, MD
CardioExchange welcomes Dr. Henry N. Ginsberg to discuss the findings of the ACCORD Lipid Study Group. In this paper, researchers randomized 5,500 diabetic patients to fenofibrate therapy versus placebo. All patients received simvastatin. Although triglyceride levels improved markedly with fenofibrate, the incidence of cardiovascular events was not affected. CardioExchange Editors: Should we abandon fenofibrate for treating […]